Skip to content

Odense Androgen Study - The effect of Testim vs strength training i a populationbased, randomised, placebocontrolled, doubleblinded study in hypogonadal men - OAS/testim

Odense Androgen Study - The effect of Testim vs strength training i a populationbased, randomised, placebocontrolled, doubleblinded study in hypogonadal men - OAS/testim

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-001690-28-DK
Enrollment
Unknown
Registered
2007-06-19
Start date
2007-09-12
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

This study will prodvide information on the Metabolic syndrome and the relationship with hypogonadism in older men. MedDRA version: 9.1 Level: LLT Classification code 10021011 Term: Hypogonadism male

Interventions

Trade Name: Testim Product Name: Testim Product Code: - Pharmaceutical Form: Gel Pharmaceutical form of the placebo: Gel Route of administration of the placebo: Cutaneous use

Sponsors

Dept of Endocrinology, Odense University Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Male 60-78 years Biochemically verified hypogonadism Waist > 94 cm Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Hematorit > 0,50 Known prostate cancer or PSA > 4 known malignant disease Alcohol or Drug abuse BMI > 40

Design outcomes

Primary

MeasureTime frame
Main Objective: 1) The effect of Testosterone (testim) in a randomized doubleblinded plcebocontrolled study on body composition, liverfat and cardiovascular risk parameters 2) The Effect of training on body composition, liverfat and cardiovascular risk parameters 3)Compare the effect of testosterone and training on body composition, liverfat and cardiovascular risk parameters 4) Investigate the effect of training on the serum level of Testosterone;Secondary Objective: ;Primary end point(s): Lean Body Mass

Countries

Denmark

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026